Questcor Pharmaceuticals, Inc. (QCOR)

[ronpopeil]

Questcor announces preliminary Q4 operating metrics
In preparation for meetings starting Monday, January 9 with investors and an investor presentation scheduled for 10:00 a.m. Thursday, January 12 at the J. P. Morgan Healthcare Conference, Questcor Pharmaceuticals announced the following preliminary operating metrics for the fourth quarter 2011: Approximately 935-950 paid H.P. Acthar Gel prescriptions for the treatment of multiple sclerosis exacerbations during the quarter, up approximately 165% from the year ago quarter ended December 31, 2010; Approximately 140-150 paid Acthar prescriptions for the treatment of nephrotic syndrome during the quarter, up approximately 145% sequentially from the third quarter of 2011; Approximately 120-125 pai d Acthar prescriptions for the treatment of infantile spasms during the quarter, representing a new high for any quarter since Questcor formed its reimbursement support center and began tracking Acthar prescriptions in August 2007; 3,360 shipped vials of Acthar, up 100% from the quarter ended December 31, 2010. :theflyonthewall